Abbott Recognizes Clondalkin Pharma & Healthcare North America as Winner of Supplier Excellence Award
Abbott has recognized Clondalkin Pharma & Healthcare North America, formerly Keller Crescent, as one of 36 companies selected worldwide for its Supplier Excellence Award. Winners were recognized for exceptional contributions to Abbott in 2009, and were chosen from more than 20,000 worldwide suppliers based on outstanding performance in supplying quality materials, equipment, and services to Abbott.
"Abbott's reputation for delivering quality products to patients is a direct result of our collaborative approach to supplier relationships," said Sarah Catterson, divisional vice president, corporate purchasing, Abbott. "We're pleased to recognize these companies that consistently achieve the highest levels of excellence."
"Beyond our people, one of our biggest strengths is the Abbott / Clondalkin Pharma & Healthcare North America relationship," said Bill Mitchell, chief executive officer at Clondalkin Pharma & Healthcare North America. "The relationship is multi-tiered and allows for excellent communication at all organizational levels, both internally and externally. This level of communication affords us the ability to adapt to any situation or need."
The Abbott Supplier Performance Program began in 1991 and assesses supplier performance using key performance indicators and feedback from internal Abbott employees in all divisions and functional areas involved with the supplier. Program suppliers are measured in the categories of quality, delivery performance, service levels, cost effectiveness, process improvement and innovation.
Of Abbott's 20,000 plus suppliers, Clondalkin Pharma & Healthcare North America has been selected among the best of the best; less than 2% of the top 1% of suppliers. "This is a high honor and a result of our dedication and commitment to servicing Abbott's needs," said Tim Wallensack, national account manager at Clondalkin Pharma & Healthcare North America.